Australians Still Buying High-Dose B6 Supplements Despite TGA Warning

Millions of Australians are continuing to purchase high-dose vitamin B6 supplements even as the national medicines regulator has moved to restrict their sale and issued repeated warnings about serious health risks tied to excessive intake.

The Therapeutic Goods Administration has flagged that prolonged consumption of large amounts of pyridoxine — the chemical name for vitamin B6 — can trigger peripheral neuropathy, a form of nerve damage that causes numbness, burning pain and tingling in the hands and feet. In severe cases, the condition can affect a person's ability to walk and may take months or years to resolve, even after stopping the supplements.

Despite those warnings, sales data and pharmacy reports suggest demand has not significantly eased. Many consumers continue to seek out high-strength B6 products for conditions including premenstrual syndrome, morning sickness during pregnancy and general fatigue — often without consulting a doctor or pharmacist about appropriate dosing.

The TGA has progressively tightened the rules around how much B6 can be included in over-the-counter products. Supplements containing more than 100 milligrams per daily dose are now required to carry prominent label warnings, and products above certain thresholds have been reclassified to require pharmacist involvement at point of sale. Regulators argue those steps have not gone far enough given the continued availability of high-dose formulations through online retailers and bulk supplement stores.

Health professionals say part of the problem lies in how widely B6 is perceived as harmless. Because it is a water-soluble vitamin naturally found in foods like chicken, fish, potatoes and bananas, many people assume that more is better or, at worst, neutral. That assumption is wrong, according to neurologists who have treated patients presenting with B6 toxicity after taking doses well above what the body can safely process.

Nerve damage from B6 overload typically begins subtly — a pins-and-needles sensation in the fingers or toes — before progressing to weakness and unsteady movement. The insidious nature of the onset means many patients are unaware the supplement is the cause, sometimes continuing to take it while symptoms worsen.

Consumer advocacy groups have called on the TGA to impose stricter dose caps and to require clearer front-of-pack warnings that spell out the neuropathy risk in plain language. They argue that current label requirements bury the risk information in fine print that shoppers rarely read before purchasing.

The TGA has acknowledged the ongoing concern and indicated it is reviewing whether further regulatory steps are warranted. In the meantime, the agency is urging Australians to check the B6 content of any supplement they currently take — including multivitamins and combined B-complex products, where B6 can accumulate alongside other sources — and to speak with a GP or pharmacist if they experience any unusual sensations in their limbs.

Doctors recommend that anyone seeking B6 supplementation for a specific health condition get a blood test first to confirm a genuine deficiency before starting a course, and to avoid self-prescribing at doses above the recommended dietary intake without professional guidance.